Krystyna M. Wozniak - Concepedia

Author

Krystyna M. Wozniak

Johns Hopkins University

Also Known As

KRYSTYNA WOZNIAK, Krystyna M Wozniak, Krystyna M. Wozniak, Krystyna Wozniak, Krystyna Woźniak, Wozniak, Krystyna

Publications

Citations

H-Index

Concepts

All Affiliations

Johns Hopkins University Johns Hopkins Medicine Guilford College Eisai (United States)National Institute of Mental Health

About

Krystyna M. Wozniak is an author at Johns Hopkins University specializing in medicine, pharmacology, and neuropharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	44	2K
2	Natural Sciences	12	12	460
3	Social Sciences	11	12	878
4	Health Sciences	4	4	143
5	Public Health	1	1	91

Krystyna M. Wozniak

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
Selective inhibition of NAALADase, which converts NAAG to glutamate, reduces ischemic brain injury Barbara S. Slusher, James J. Vornov, Ajit G. Thomas, Nature Medicine Selective InhibitionNeurophysiologyMedicineNeuropharmacologyBrain Injury	1999	300
Focal application of alcohols elevates extracellular dopamine in rat brain: a microdialysis study Krystyna M. Wozniak, Agu Pert, Andrea Mele, Brain Research Focal ApplicationNeurophysiologyAddictionMicrodialysis StudyMedicine	1991	149
Antagonism of 5-HT3 receptors attenuates the effects of ethanol on extracellular dopamine Krystyna M. Wozniak, Agu Pert, Markku Linnoila European Journal of Pharmacology 5-Ht3 ReceptorsAlcohol DependenceAddictionMedicinePhysiology	1990	143
Glutamate carboxypeptidase II inhibition protects motor neurons from death in familial amyotrophic lateral sclerosis models Ghanashyam D. Ghadge, Barbara S. Slusher, Amos Bodner, Proceedings of the National Academy of Sciences	2003	119
Synthesis and Biological Evaluation of Thiol-Based Inhibitors of Glutamate Carboxypeptidase II: Discovery of an Orally Active GCP II Inhibitor Pavel Majer, Paul Jackson, Greg Delahanty, Journal of Medicinal Chemistry Molecular PainPharmacotherapyChemical BiologyPharmaceutical ChemistryMedicinal Chemistry	2003	106
Comparison of Neuropathy-Inducing Effects of Eribulin Mesylate, Paclitaxel, and Ixabepilone in Mice Krystyna M. Wozniak, K. Nomoto, Rena G. Lapidus, Cancer Research Digital Nerve AmplitudesChemoprevention StrategyNeuropathic PainPathologyPharmacotherapy	2011	93
Food intake, neuroendocrine and temperature effects of 8-OHDPAT in the rat Charanjit S. Aulakh, Krystyna M. Wozniak, Marcus Haas, European Journal of Pharmacology Animal PhysiologyNutritionEnergy HomeostasisBehavioral NeurosciencePhysiology	1988	91
Design and Pharmacological Activity of Phosphinic Acid Based NAALADase Inhibitors Paul Jackson, Kevin L. Tays, Keith M. Maclin, Journal of Medicinal Chemistry Naaladase InhibitorsPharmacotherapyExperimental PharmacologyMedicinal ChemistryPharmacological Study	2001	91
GCP II (NAALADase) Inhibition Suppresses Mossy Fiber-CA3 Synaptic Neurotransmission by a Presynaptic Mechanism E Sanabria, Krystyna M. Wozniak, Barbara S. Slusher, Journal of Neurophysiology	2004	74
Mice lacking glutamate carboxypeptidase II are protected from peripheral neuropathy and ischemic brain injury Dean J. Bacich, Krystyna M. Wozniak, Xi Lu, Journal of Neurochemistry	2005	65

Page 1